onepharm is a Vienna, Austria based innovative dental-pharmaceutical company.

Dr. Bernhard Küenburg, CEO and founder was previously Senior Vice president Marketing, Sales and Development at Siegfried, a leading custom manufacturer of small molecule drug substances in Switzerland. He was responsible for strategic collaboration contracts, customer contacts and strategic pipeline development. Prior to this he was general manager at CarboGen Laboratories, where he managed the construction and operation of the CarboGen Neuland facility. Previously he was department head at Sanochemia in Austria, responsible for the development and manufacturing of the Alzheimer drug Galanthamin. Mr. Küenburg has a PhD in organic chemistry from the Vienna University of Technology.


a.o. Univ.Prof. Dr. Doblhoff-Dier, COO and co-founder was previously Vice President for global manufacturing at Aphton/Igeneon, responsible for process development, manufacturing collaborations, quality systems and documentation. Prior to this he was professor for bioprocess engineering and headed construction and production at the GMP pilot plant of the Institute for Applied Microbiology at the University of Applied Life Sciences, Vienna. Additionally he is an expert for Biosafety and member of different international biosafety boards and working groups. He holds a PhD in biotechology.


Angelika Bodenteich, MD, Chief Medical Officer previously headed Research and Development at Sanochemia Pharmazeutika AG. Prior to this she held research positions at the Ludwig-Boltzmann-Institute for Neurooncology in the area of anti-neuronal antibodies, Nycomed Pharma in the area of molecular biology and pharmacology, the National Institute of Mental Health in Washington, D.C. and the University of Oklahoma in the area of mitochondrial genetics and sequencing of chromosome 22 for the Human Genome Project. Additionally to her medical doctorate Angelika has specialized in the field of pathology (Facharzt für Pathologie) and is a certified Senior Project Manager (IPMA). Apart from numerous scientific publications, Angelika can draw from a long experience in pharmaceutical development, project management and business development in the pharmaceutical industry.